is microdosing tirzepatide effective for weight loss GLP-1s aren't just loss. ✨⁠ ⁠ GLP-1s becoming increasingly popular for those looking to support their overall health and wellness, not just the number on the scale.⁠ ⁠ Microdosing GLP‑1 at 40+: Tirzepatide

In 95 DPP4-Is trials (1,488 strokes, 109,243 participants), DPP4-Is use did not decrease stroke risk (RR: 0.91, 95% CI [0.83, 1.01], p = 0.07) vs

Science backed treatment Ongoing clinical support Trusted by 100k customers across the UK Lower starting doses tested: 1mg weekly: Tested in the phase 2 obesity trials as a fixed dose with no escalation

No structured family-history capture beyond MTC/MEN-2

Frequently Asked Questions What is the BPC-157 + TB-500 spray and how does it work

This multifaceted approach to evaluating GLP-1 therapies demands efficient processes and technologies to manage complex data collection across primary, secondary, and exploratory endpoints